tiprankstipranks
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market

Avidity Biosciences (RNA) Income Statement

Compare
754 Followers

Avidity Biosciences Income Statement

Last quarter (Q4 2024), Avidity Biosciences's total revenue was $2.97M, an increase of 35.57% from the same quarter last year. In Q4, Avidity Biosciences's net income was $-102.26M. See Avidity Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.90M$ 9.56M$ 9.22M$ 9.33M$ 6.79M
Gross Profit
$ 10.90M$ 7.46M$ 7.84M$ 8.69M$ -30.82M
Operating Expenses
$ 389.83M$ 245.16M$ 188.14M$ 127.38M$ 51.06M
Depreciation and Amortization
$ 0.00$ 2.10M$ 1.39M$ 639.00K$ 373.00K
EBITDA
$ -378.94M$ -233.50M$ -177.53M$ -117.41M$ -43.77M
Operating Income
$ -378.94M$ -235.60M$ -178.91M$ -118.05M$ -44.28M
Other Income/Expenses
$ 56.63M$ 23.38M$ 4.92M$ 42.00K$ -78.00K
Pretax Income
$ -322.30M$ -212.22M$ -174.00M$ -118.01M$ -44.35M
Net Income
$ -322.30M$ -212.22M$ -169.08M$ -117.37M$ -43.98M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.89$ -2.91$ -3.24$ -2.83$ -2.03
Diluted EPS
$ -2.89$ -2.91$ -3.24$ -2.83$ -2.03
Weighted Average Shares Outstanding
111.58M 73.01M 52.16M 41.43M 21.66M
Weighted Average Shares Outstanding (Diluted)
111.58M 73.01M 52.16M 41.43M 21.66M
Currency in USD

Avidity Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis